View Clinical Trial (Medical Research Study)


Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians - NCT00949611-55902(Clinical Trial 304125)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Rochester
State:  
MN
Zip Code: 55902
Conditions: Osteoporosis - Osteopenia - Fragility Fractures
Purpose: Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. FRAX (Fracture Risk Assessment Tool) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of: - FRAX - FRAX + decision aid - Usual care (no decision aid and no FRAX given to clinician)
Study summary:
Criteria: Inclusion Criteria: - Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90 - BMD T-Score < 1.0 - Have appointment with clinician to discuss test results and treatment options - Patients with FRAX <20% risk who have taken a bisphosphonate for < 5 years. Exclusion Criteria: - Unable to speak or read English
Study is available at: Mayo Clinic
Rochester, MN 55902
United States

Primary Contact:
Laurie J Pencille, B.A., CRSC
Email: pencille.laurie@mayo.edu
Phone: 507-538-6801

Secondary Contact:
Laurie J Pencille, BA, CRSC
Email: pencille.laurie@mayo.edu
Phone: (507)538-6801
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.